Table 3.
Clinical Profile of study participants [N = 86].
| Variables | Orphans N = 56 | Nonorphans N = 30 | Total N = 86 |
|---|---|---|---|
| Median CD4 count (IQR) | 872.50 (545–1035) | 848.50 (560.25–1228.75) | 853.50 (552–1092) |
| CD4 count (cells/microliter) ∗ | n (%) | n (%) | n (%) |
| <200 | 02 (03.6) | 01 (03.3) | 03 (03.5) |
| 200–499 | 09 (16.1) | 04 (13.3) | 13 (15.1) |
| ≥500 | 45 (80.4) | 25 (83.3) | 70 (81.4) |
| Currently on HAART | |||
| Yes | 49 (87.5) | 25 (83.3) | 74 (86.0) |
| No | 07 (12.5) | 05 (16.7) | 12 (14.0) |
| Duration of treatment [N = 74] | |||
| Less than 1 year | 03 (05.4) | 01 (03.3) | 04 (04.7) |
| 1–5 years | 16 (28.6) | 14 (46.7) | 30 (34.9) |
| More than 5 years | 37 (66.1) | 15 (50.0) | 52 (60.5) |
| Mode of Transmission | |||
| Vertical | 56 (100) | 30 (100) | 86 (100) |
| Immunization status | |||
| Completely immunized for age | 56 (100) | 30 (100) | 86 (100) |
∗At the time of study.